ABSTRACT
Background Measurement of coronary microvascular resistance (MR) is essential for diagnosing nonocclusive coronary artery ischemia, but whether coronary branches of different diameters can be similarly assessed using hyperemic microvascular resistance index (hMVRI) calculated from average peak velocity (APV) remains unclear.
Objectives We investigated the relationship between coronary arteries of different diameters and hMVRI.
Method Thirty patients with suspected angina pectoris and nonobstructive coronary stenosis with fractional flow reserve >0.8 underwent evaluation of all coronary arteries using a Doppler velocity and pressure-equipped guidewire. Vessel diameter (DQCA) was analyzed by quantitative coronary angiography (QCA). Coronary blood flow (CBFQCA) was calculated as πDQCA2/4 (0.5×APV) and hMVRI as distal coronary pressure (Pd) divided by CBFDQCA during maximal hyperemia.
Results The hMVRI was significantly higher for the right coronary artery (RCA) than for the left anterior descending artery (LAD), but no significant differences between arteries were seen for CBFQCA and hMVRIQCA. Although the correlation between CBFQCA and APV was weak in all arteries, CBFQCA divided into three groups according to DQCA showed very strong correlations with APV. Slopes of the straight line between APV and CBFQCA for small-, middle-, and large-diameter groups were 0.48, 0.30, and 0,21, respectively, with slope decreasing as diameter increased. The correlation between APV and CBFQCA was high for LAD and RCA, but weak for the left circumflex artery.
Conclusions Evaluation of MR in coronary branches requires consideration of vessel diameter.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
he Ethics Committee at Ureshino Medical Center
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Abbreviations List
- hMVRI
- hyperemic microvascular resistance index
- APV
- average peak velocity
- CBF
- coronary blood flow
- QCA
- quantitative coronary angiography
- CMD
- coronary microvascular dysfunction
- INOCA
- ischemia with no obstructive coronary arteries
- MVA
- microvascular angina
- DQCA
- vessel diameter analyzed by quantitative coronary angiography
- CBFQCA
- coronary blood flow by quantitative coronary angiography
- hMVRIQCA
- hyperemic microvascular resistance index by quantitative coronary angiography
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.